Genomic-scale prioritization of drug targets: the TDR Targets database
- PMID: 18927591
- PMCID: PMC3184002
- DOI: 10.1038/nrd2684
Genomic-scale prioritization of drug targets: the TDR Targets database
Abstract
The increasing availability of genomic data for pathogens that cause tropical diseases has created new opportunities for drug discovery and development. However, if the potential of such data is to be fully exploited, the data must be effectively integrated and be easy to interrogate. Here, we discuss the development of the TDR Targets database (http://tdrtargets.org), which encompasses extensive genetic, biochemical and pharmacological data related to tropical disease pathogens, as well as computationally predicted druggability for potential targets and compound desirability information. By allowing the integration and weighting of this information, this database aims to facilitate the identification and prioritization of candidate drug targets for pathogens.
Figures
References
-
- Nwaka S, Hudson A. Innovative lead discovery strategies for tropical diseases. Nat Rev Drug Discov. 2006;5:941–55. - PubMed
-
- Heby O, Persson L, Rentala M. Targeting the polyamine biosynthetic enzymes: a promising approach to therapy of African sleeping sickness, Chagas' disease, and leishmaniasis. Amino Acids. 2007;33:359–66. - PubMed
-
- Mori M, et al. Contribution of structural biology to clinically validated target proteins. Drug Discov Today. 2008;13:469–472. - PubMed
-
- Varghese JN. Development of neuraminidase inhibitors as anti-influenza virus drugs. Drug Dev Res. 1999;46:176–196.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
